Pratia

Fortrea Convenes New Site Advisory Board

Retrieved on: 
Wednesday, December 13, 2023
Ecosystem, Partnership, Trust, Research, Clinical trial, Human, Overalls, Patient, Acceleration, Pratia, Pharmaceutical industry

The Site Advisory Board will be responsible for providing insight and feedback on strategies and solutions proposed regarding sites, patients, trial operations and relevant technology.

Key Points: 
  • The Site Advisory Board will be responsible for providing insight and feedback on strategies and solutions proposed regarding sites, patients, trial operations and relevant technology.
  • “The formation of the Site Advisory Board marks an acceleration of our site-focused strategy and includes representation from incredibly impressive leaders, creating a think tank for our industry.
  • “We are very supportive of Fortrea employing an innovative new approach to engage with healthcare site partnership providers, who are key to delivering successful research results, early in the planning process.”
    “FutureMeds is delighted to join the Fortrea Site Advisory Board to build better understanding between key stakeholders in the clinical research industry,” said Radek Janiak, chief executive officer at FutureMeds.
  • “Fortrea’s genuine commitment to building a forum and working relationships through the Site Advisory Board exhibits dedication to progress for all stakeholders in research and, most of all, the patients.”

Pratia's study says: Poles, Bulgarians, and Ukrainians are ready to take part in clinical trials but too often trust the unverified information available online.

Retrieved on: 
Thursday, December 15, 2022
NHS, CAWI, Attitude, Prognosis, Ageing, Risk, CEE, Patient, Disease, ARC, Behavior, Multimedia, Clinical trial, Health, Pharmaceutical industry, Pratia

The study aimed to uncover the Patients' opinions and behavior regarding clinical trials.It's part of Pratia's patient-centricity strategy.

Key Points: 
  • The study aimed to uncover the Patients' opinions and behavior regarding clinical trials.It's part of Pratia's patient-centricity strategy.
  • The results from the survey show a high level of awareness of the term "clinical trials."
  • 52% Bulgarian, 55% Polish, and 43% Ukrainian respondents would participate in a clinical trial if they could and had to.
  • Pratia conducted 1,500+ clinical trials involving 300,000+ patients in its 90+ research sites in six countries, covering 85%+ therapeutic areas.

Decentralized Clinical Trials: Implementation of a Hybrid Model From a Site and Sponsor Perspective During Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Monday, November 15, 2021
DCTS, Industry, Hybrid models of forest production, Partner, MD, Speech, CEO, Doctor of Philosophy, Pratia, Site, Running, Janssen Pharmaceuticals, Board, Patient, Pi, Food, Johnson & Johnson, IMI, Physician, Medical device, Television, Health insurance, Pharmaceutical industry

This webinar Decentralized Clinical Trials: Implementation of a Hybrid Model from a Site and Sponsor Perspective will focus on discussing the flexible tools necessary for adapting work to a number of different clinical trial models, including site-based, hybrid and virtual trials.

Key Points: 
  • This webinar Decentralized Clinical Trials: Implementation of a Hybrid Model from a Site and Sponsor Perspective will focus on discussing the flexible tools necessary for adapting work to a number of different clinical trial models, including site-based, hybrid and virtual trials.
  • More information and register for this event on page: Decentralized Clinical Trials: Implementation of a Hybrid Model from a Site and Sponsor Perspective.
  • Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
  • Information about hosting a webinar: http://xtalks.com/why-host-a-webinar/
    Ayesha Rashid, Xtalks, +1 (416) 977-6555 x 272, [email protected]

Pratia Teams with VirTrial to Become First ‘Virtual Trial Capable’ Site Network in Europe

Retrieved on: 
Monday, October 14, 2019
Health, Clinical research, Articles, Pharmaceutical industry, Clinical pharmacology, Design of experiments, Clinical trials, Pratia

SCOTTSDALE, Ariz., Oct. 14, 2019 (GLOBE NEWSWIRE) -- VirTrial today announced an alliance with Pratia , the largest network of clinical research centers in Europe.

Key Points: 
  • SCOTTSDALE, Ariz., Oct. 14, 2019 (GLOBE NEWSWIRE) -- VirTrial today announced an alliance with Pratia , the largest network of clinical research centers in Europe.
  • All Pratia research centers have completed VirTrials Virtual Trial Capable training, making them the first site network in Europe to become trained and certified as Virtual Trial Capable and prepared to conduct decentralized clinical trials (DCT).
  • Participants receive a Virtual Trial Capable certificate and badge to highlight to sponsors and CROs that they are prepared to conduct hybrid decentralized clinical trials.
  • Our network is expanding across Europe and we plan to maintain our 100% Virtual Trial Capable status with VirTrial to best serve our patients and pharma sponsors.

Pratia Teams with VirTrial to Become First ‘Virtual Trial Capable’ Site Network in Europe

Retrieved on: 
Thursday, October 10, 2019
Technology, General Health, Health, Research, Audio, Video, Internet, Science, Clinical trials, Health, Clinical research, Pharmaceutical industry, Medical research, Clinical pharmacology, Clinical trial, Design of experiments, VirTrial, Pratia

All Pratia research centers have completed VirTrials Virtual Trial Capable training, making them the first site network in Europe to become trained and certified as Virtual Trial Capable and prepared to conduct decentralized clinical trials (DCT).

Key Points: 
  • All Pratia research centers have completed VirTrials Virtual Trial Capable training, making them the first site network in Europe to become trained and certified as Virtual Trial Capable and prepared to conduct decentralized clinical trials (DCT).
  • Participants then receive a Virtual Trial Capable certificate and badge to highlight to sponsors and CROs that they are prepared to conduct hybrid decentralized clinical trials.
  • Our network is expanding across Europe and we plan to maintain our 100% Virtual Trial Capable status with VirTrial to best serve our patients and pharma sponsors.
  • For more information on the Virtual Trial Capable certificate program and to access the training modules, go to https://virtrial.com/research-sites/ .